angiotensin ii has been researched along with scoparone in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fu, B; Ma, X; Mu, C; Su, Y; Yu, F | 1 |
| Chen, J; Chen, Y; Fang, L; Gao, H; Li, H; Lin, J; Lv, R; Lyu, L; Wang, W; Xu, F; Yan, T | 1 |
2 other study(ies) available for angiotensin ii and scoparone
| Article | Year |
|---|---|
Scoparone attenuates angiotensin II-induced extracellular matrix remodeling in cardiac fibroblasts.
Topics: Angiotensin II; Animals; Artemisia; Cardiomyopathies; Cell Differentiation; Cell Proliferation; Cells, Cultured; Collagen Type I; Coumarins; Extracellular Matrix; Fibroblasts; Fibronectins; Fibrosis; Myocardium; Myofibroblasts; Phytotherapy; Rats; Signal Transduction; Smad Proteins; Transforming Growth Factor beta1 | 2018 |
Scoparone alleviates Ang II-induced pathological myocardial hypertrophy in mice by inhibiting oxidative stress.
Topics: Angiotensin II; Animals; Antioxidants; Biomarkers; Biopsy; Blood Pressure; Cardiomegaly; Collagen; Coumarins; Disease Management; Disease Models, Animal; Disease Susceptibility; Echocardiography; Fibroblasts; Immunohistochemistry; Male; Mice; Myocytes, Cardiac; Oxidative Stress; Rats | 2021 |